CARGO Reconciled Depreciation vs Ebit Analysis

CRGX Stock

15.73 0.09 0.57%

CARGO Therapeutics, financial indicator trend analysis is way more than just evaluating CARGO Therapeutics, prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CARGO Therapeutics, is a good investment. Please check the relationship between CARGO Therapeutics, Reconciled Depreciation and its Ebit accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CARGO Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Reconciled Depreciation vs Ebit

Reconciled Depreciation vs Ebit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CARGO Therapeutics, Reconciled Depreciation account and Ebit. At this time, the significance of the direction appears to have pay attention.

The correlation between CARGO Therapeutics,'s Reconciled Depreciation and Ebit is -0.95. Overlapping area represents the amount of variation of Reconciled Depreciation that can explain the historical movement of Ebit in the same time period over historical financial statements of CARGO Therapeutics, Common, assuming nothing else is changed. The correlation between historical values of CARGO Therapeutics,'s Reconciled Depreciation and Ebit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Reconciled Depreciation of CARGO Therapeutics, Common are associated (or correlated) with its Ebit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit has no effect on the direction of Reconciled Depreciation i.e., CARGO Therapeutics,'s Reconciled Depreciation and Ebit go up and down completely randomly.

Correlation Coefficient

-0.95

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Reconciled Depreciation

Ebit

Most indicators from CARGO Therapeutics,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CARGO Therapeutics, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CARGO Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

At this time, CARGO Therapeutics,'s Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 521.4 M in 2024, whereas Enterprise Value Over EBITDA is likely to drop (6.51) in 2024.

	2010	2022	2023	2024 (projected)
Total Operating Expenses	6.0M	34.8M	96.7M	50.4M
Cost Of Revenue	147K	1.4M	3.7M	1.9M

Total Operating Expenses Cost Of Revenue

CARGO Therapeutics, fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt
Total Assets		0.78	0.61	0.5	1.0	1.0	0.89	-1.0	-0.98	0.83	1.0	1.0	1.0	1.0	0.92	1.0	1.0	0.79	1.0	0.75	1.0	1.0	1.0	0.9	1.0	0.12
Short Long Term Debt Total	0.78		0.95	0.9	0.74	0.79	0.93	-0.76	-0.9	0.99	0.78	0.8	0.81	0.78	0.78	0.76	0.76	1.0	0.8	1.0	0.76	0.8	0.78	0.95	0.73	0.69
Other Current Liab	0.61	0.95		0.99	0.55	0.62	0.78	-0.57	-0.76	0.91	0.6	0.63	0.65	0.6	0.55	0.58	0.57	0.94	0.63	0.97	0.58	0.63	0.6	0.81	0.54	0.86
Total Current Liabilities	0.5	0.9	0.99		0.44	0.53	0.68	-0.46	-0.67	0.84	0.5	0.53	0.55	0.5	0.43	0.47	0.47	0.88	0.54	0.93	0.48	0.53	0.5	0.72	0.44	0.92
Total Stockholder Equity	1.0	0.74	0.55	0.44		1.0	0.86	-1.0	-0.96	0.79	1.0	1.0	0.99	1.0	0.92	1.0	1.0	0.75	0.99	0.7	1.0	0.99	1.0	0.88	1.0	0.05
Property Plant And Equipment Net	1.0	0.79	0.62	0.53	1.0		0.89	-1.0	-0.98	0.84	1.0	1.0	1.0	1.0	0.91	1.0	1.0	0.81	1.0	0.76	1.0	1.0	1.0	0.91	0.99	0.15
Current Deferred Revenue	0.89	0.93	0.78	0.68	0.86	0.89		-0.89	-0.95	0.97	0.88	0.89	0.9	0.88	0.95	0.87	0.87	0.94	0.9	0.91	0.88	0.89	0.89	1.0	0.86	0.4
Net Debt	-1.0	-0.76	-0.57	-0.46	-1.0	-1.0	-0.89		0.97	-0.82	-1.0	-1.0	-0.99	-1.0	-0.94	-1.0	-1.0	-0.78	-1.0	-0.72	-1.0	-1.0	-1.0	-0.9	-1.0	-0.08
Retained Earnings	-0.98	-0.9	-0.76	-0.67	-0.96	-0.98	-0.95	0.97		-0.93	-0.97	-0.98	-0.99	-0.97	-0.91	-0.97	-0.97	-0.91	-0.98	-0.87	-0.97	-0.98	-0.98	-0.96	-0.96	-0.33
Accounts Payable	0.83	0.99	0.91	0.84	0.79	0.84	0.97	-0.82	-0.93		0.83	0.84	0.86	0.83	0.85	0.81	0.81	1.0	0.85	0.98	0.81	0.85	0.83	0.98	0.79	0.6
Cash	1.0	0.78	0.6	0.5	1.0	1.0	0.88	-1.0	-0.97	0.83		1.0	1.0	1.0	0.92	1.0	1.0	0.79	1.0	0.74	1.0	1.0	1.0	0.9	1.0	0.12
Non Current Assets Total	1.0	0.8	0.63	0.53	1.0	1.0	0.89	-1.0	-0.98	0.84	1.0		1.0	1.0	0.91	1.0	1.0	0.81	1.0	0.76	1.0	1.0	1.0	0.91	0.99	0.15
Non Currrent Assets Other	1.0	0.81	0.65	0.55	0.99	1.0	0.9	-0.99	-0.99	0.86	1.0	1.0		1.0	0.91	1.0	1.0	0.82	1.0	0.78	1.0	1.0	1.0	0.92	0.99	0.17
Cash And Short Term Investments	1.0	0.78	0.6	0.5	1.0	1.0	0.88	-1.0	-0.97	0.83	1.0	1.0	1.0		0.92	1.0	1.0	0.79	1.0	0.74	1.0	1.0	1.0	0.9	1.0	0.12
Common Stock Shares Outstanding	0.92	0.78	0.55	0.43	0.92	0.91	0.95	-0.94	-0.91	0.85	0.92	0.91	0.91	0.92		0.92	0.92	0.8	0.91	0.74	0.92	0.91	0.92	0.94	0.92	0.1
Non Current Liabilities Total	1.0	0.76	0.58	0.47	1.0	1.0	0.87	-1.0	-0.97	0.81	1.0	1.0	1.0	1.0	0.92		1.0	0.77	1.0	0.72	1.0	1.0	1.0	0.89	1.0	0.09
Capital Lease Obligations	1.0	0.76	0.57	0.47	1.0	1.0	0.87	-1.0	-0.97	0.81	1.0	1.0	1.0	1.0	0.92	1.0		0.77	1.0	0.72	1.0	1.0	1.0	0.89	1.0	0.08
Other Current Assets	0.79	1.0	0.94	0.88	0.75	0.81	0.94	-0.78	-0.91	1.0	0.79	0.81	0.82	0.79	0.8	0.77	0.77		0.81	0.99	0.77	0.81	0.79	0.96	0.75	0.67
Other Stockholder Equity	1.0	0.8	0.63	0.54	0.99	1.0	0.9	-1.0	-0.98	0.85	1.0	1.0	1.0	1.0	0.91	1.0	1.0	0.81		0.77	1.0	1.0	1.0	0.91	0.99	0.16
Total Liab	0.75	1.0	0.97	0.93	0.7	0.76	0.91	-0.72	-0.87	0.98	0.74	0.76	0.78	0.74	0.74	0.72	0.72	0.99	0.77		0.73	0.77	0.74	0.92	0.69	0.73
Net Invested Capital	1.0	0.76	0.58	0.48	1.0	1.0	0.88	-1.0	-0.97	0.81	1.0	1.0	1.0	1.0	0.92	1.0	1.0	0.77	1.0	0.73		1.0	1.0	0.89	1.0	0.09
Property Plant And Equipment Gross	1.0	0.8	0.63	0.53	0.99	1.0	0.89	-1.0	-0.98	0.85	1.0	1.0	1.0	1.0	0.91	1.0	1.0	0.81	1.0	0.77	1.0		1.0	0.91	0.99	0.15
Total Current Assets	1.0	0.78	0.6	0.5	1.0	1.0	0.89	-1.0	-0.98	0.83	1.0	1.0	1.0	1.0	0.92	1.0	1.0	0.79	1.0	0.74	1.0	1.0		0.9	1.0	0.12
Capital Stock	0.9	0.95	0.81	0.72	0.88	0.91	1.0	-0.9	-0.96	0.98	0.9	0.91	0.92	0.9	0.94	0.89	0.89	0.96	0.91	0.92	0.89	0.91	0.9		0.87	0.43
Net Working Capital	1.0	0.73	0.54	0.44	1.0	0.99	0.86	-1.0	-0.96	0.79	1.0	0.99	0.99	1.0	0.92	1.0	1.0	0.75	0.99	0.69	1.0	0.99	1.0	0.87		0.04
Short Term Debt	0.12	0.69	0.86	0.92	0.05	0.15	0.4	-0.08	-0.33	0.6	0.12	0.15	0.17	0.12	0.1	0.09	0.08	0.67	0.16	0.73	0.09	0.15	0.12	0.43	0.04

Click cells to compare fundamentals

CARGO Therapeutics, Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GOOG	Alphabet Inc Class C
CRM	Salesforce

Additional Tools for CARGO Stock Analysis

When running CARGO Therapeutics,'s price analysis, check to measure CARGO Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CARGO Therapeutics, is operating at the current time. Most of CARGO Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of CARGO Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CARGO Therapeutics,'s price. Additionally, you may evaluate how the addition of CARGO Therapeutics, to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CARGO Reconciled Depreciation vs Ebit Analysis

Reconciled Depreciation vs Ebit

Reconciled Depreciation vs Ebit Correlation Analysis

Correlation Coefficient

Reconciled Depreciation

Ebit

CARGO Therapeutics, fundamental ratios Correlations

CARGO Therapeutics, Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for CARGO Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Property Plant And Equipment Net	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Non Currrent Assets Other	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets

Net Working Capital	- 1.0	Net Debt
Total Current Assets	- 1.0	Net Debt
Property Plant And Equipment Gross	- 1.0	Net Debt
Net Invested Capital	- 1.0	Net Debt
Other Stockholder Equity	- 1.0	Net Debt
Capital Lease Obligations	- 1.0	Net Debt